Infectious Disease Therapeutics and Drug Development
The continuous evolution of infectious pathogens and the emergence of drug-resistant microorganisms have created an urgent need for innovative therapeutic strategies and accelerated drug development efforts. Infectious disease therapeutics play a critical role in reducing disease burden, improving patient outcomes, and strengthening global preparedness against current and future health threats. This session focuses on the discovery, development, evaluation, and clinical application of therapeutic interventions for infectious diseases, highlighting advances in pharmaceuticals, biologics, antiviral agents, antimicrobial therapies, immunotherapies, and precision medicine approaches. Participants will explore the latest breakthroughs in drug discovery, translational research, and clinical development pathways aimed at addressing bacterial, viral, fungal, and parasitic infections. Discussions will cover novel therapeutic targets, host-directed therapies, monoclonal antibodies, combination treatments, drug repurposing strategies, and emerging technologies that accelerate therapeutic innovation. The session will also examine challenges associated with antimicrobial resistance, treatment optimization, clinical trial design, regulatory approval processes, and equitable access to life-saving medicines. Researchers, clinicians, pharmaceutical scientists, biotechnology professionals, regulatory experts, and public health stakeholders will have opportunities to share findings related to preclinical studies, clinical investigations, therapeutic efficacy, safety assessments, and real-world treatment outcomes. Special attention will be given to personalized treatment strategies, pharmacogenomics, advanced drug delivery systems, and the integration of artificial intelligence and computational tools in drug development. Additional topics include pandemic therapeutics, emergency use authorizations, global manufacturing capacity, supply chain resilience, and collaborative partnerships that support rapid therapeutic deployment during public health emergencies. By fostering interdisciplinary collaboration and scientific exchange, this session aims to advance the development of safe, effective, and accessible treatments that improve infectious disease management and contribute to global health security. The insights generated through these discussions will support innovation, accelerate therapeutic discovery, and strengthen healthcare systems in addressing evolving infectious disease challenges worldwide.